Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.

Autor: Vallis KA; Gray Institute for Radiation Oncology and Biology, University of Oxford Oxford, UK., Reilly RM; Leslie Dan Faculty of Pharmacy, University of Toronto Toronto, Canada ; Toronto General Hospital Research Institute Toronto, Canada ; Medical Imaging, University of Toronto Toronto, Canada., Scollard D; Leslie Dan Faculty of Pharmacy, University of Toronto Toronto, Canada., Merante P; Radiation Medicine Program, Princess Margaret Hospital, University of Toronto Canada., Brade A; Radiation Medicine Program, Princess Margaret Hospital, University of Toronto Canada., Velauthapillai S; Leslie Dan Faculty of Pharmacy, University of Toronto Toronto, Canada., Caldwell C; Medical Imaging, University of Toronto Toronto, Canada ; Medical Physics, Sunnybrook Health Sciences Center Toronto, Canada., Chan I; Medical Imaging, University of Toronto Toronto, Canada., Freeman M; Medical Imaging, University of Toronto Toronto, Canada., Lockwood G; Biostatistics, Princess Margaret Hospital Toronto, Canada., Miller NA; Pathology, University Health Network Toronto, Canada., Cornelissen B; Gray Institute for Radiation Oncology and Biology, University of Oxford Oxford, UK., Petronis J; Medical Oncology and Hematology, Princess Margaret Hospital Toronto, Canada., Sabate K; Biostatistics, Princess Margaret Hospital Toronto, Canada.

Publikováno v: American journal of nuclear medicine and molecular imaging [Am J Nucl Med Mol Imaging] 2014 Mar 20; Vol. 4 (2), pp. 181-92. Date of Electronic Publication: 2014 Mar 20 (Print Publication: 2014).